CHESTER, N.J.--Sordoni Construction Company was selected as the construction manager for the Hemispherx Biopharma, Inc. facility enhancement project at their manufacturing site in New Brunswick, NJ. These improvements will enable Hemispherx to provide a high volume, more cost effective manufacturing process for Alferon N Injection® and Alferon® LDO. Alferon N Injection® is Hemispherx's injectable formulation of natural interferon which is approved by the FDA for the treatment of certain categories of genital warts. Alferon® LDO is an experimental therapeutic being developed for multiple clinical indications including prevention, prophylaxis and treatment of influenza.
Sordoni will oversee and manage this multi-million dollar renovation of the existing manufacturing suite to a more efficient, less labor intensive up-graded process. The project includes full engineering studies, capital improvements, system upgrades and introduction of building management systems to enhance production. The main building is approximately 43,000 square feet and includes process piping, vessels, a bioreactor, class 100 hoods and a cold room. New utilities, including WFI, clean steam, process chiller and an emergency generator will also be added. In order to make the space for the new process suite, an existing mezzanine level will be demolished.
ABOUT SORDONI CONSTRUCTION—Sordoni Construction Company is a full-service privately owned and operated construction management and general contracting company that was originally founded in 1910. Current and past clients include many of the most prominent companies in United States as well as many Fortune 500 companies. Sordoni is a leading provider of construction management services and strives to be recognized industry-wide for extraordinary service, creative thinking and breakthrough results. For the past 4 years Sordoni has been recognized as one of the Top 100 Privately Held Companies in New Jersey. For more information, please visit us online at www.sordoni.com.
ABOUT HEMISPHERX BIOPHARMA- Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx' flagship products include Alferon N Injection® (FDA approved for a category of sexually transmitted diseases) and the experimental therapeutics Ampligen® and Alferon® LDO. Ampligen® is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system. Hemispherx' platform technology includes components for potential treatment of various severely debilitating and life threatening diseases. Hemispherx has patents comprising its core intellectual property estate and a fully commercialized product (Alferon N Injection®). The Company wholly owns and exclusively operates a GMP certified manufacturing facility in the United States for commercial products. For more information please visit www.hemispherx.net.
Full Article
For a Complete Version of this BUSINESS WIRE Press Release
Sordoni will oversee and manage this multi-million dollar renovation of the existing manufacturing suite to a more efficient, less labor intensive up-graded process. The project includes full engineering studies, capital improvements, system upgrades and introduction of building management systems to enhance production. The main building is approximately 43,000 square feet and includes process piping, vessels, a bioreactor, class 100 hoods and a cold room. New utilities, including WFI, clean steam, process chiller and an emergency generator will also be added. In order to make the space for the new process suite, an existing mezzanine level will be demolished.
ABOUT SORDONI CONSTRUCTION—Sordoni Construction Company is a full-service privately owned and operated construction management and general contracting company that was originally founded in 1910. Current and past clients include many of the most prominent companies in United States as well as many Fortune 500 companies. Sordoni is a leading provider of construction management services and strives to be recognized industry-wide for extraordinary service, creative thinking and breakthrough results. For the past 4 years Sordoni has been recognized as one of the Top 100 Privately Held Companies in New Jersey. For more information, please visit us online at www.sordoni.com.
 |
ABOUT HEMISPHERX BIOPHARMA- Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders. Hemispherx' flagship products include Alferon N Injection® (FDA approved for a category of sexually transmitted diseases) and the experimental therapeutics Ampligen® and Alferon® LDO. Ampligen® is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system. Hemispherx' platform technology includes components for potential treatment of various severely debilitating and life threatening diseases. Hemispherx has patents comprising its core intellectual property estate and a fully commercialized product (Alferon N Injection®). The Company wholly owns and exclusively operates a GMP certified manufacturing facility in the United States for commercial products. For more information please visit www.hemispherx.net.
Full Article
For a Complete Version of this BUSINESS WIRE Press Release
 |
All comment postings require your name and email address for user verification only. Your email address will not be used or distributed for any other purpose.
No advertising is permitted and will result in the post being deleted and/or banning. Please click "REPORT" to report any inappropriate posts. blog comments powered by Disqus
Permission to Reproduce:
Unless otherwise stated, the copyright and similar rights to all material published on this website are owned by The Manufacturers Group Inc. DBA Manufacturing & Technology eJournal( mfrtech.com ). Reproduction of any article in print, electronic or any other form must acknowledge mfrtech.com as the Source and include a link to http://www.mfrtech.com
 |
